VERAVAS, Inc

Veravas is transforming laboratory diagnostics through its proprietary VeraBINDTM technology that makes early disease detection possible in any sample type. Through VeraBIND, Veravas is bringing greater patient access to high-value diagnostic tests for neurodegenerative disorders that have not been previously possible. To learn more about our technologies and clinical applications, visit veravas.com

Saliva,laboratory diagnostics,alzheimer's disease,lyme disease,celiac disease,neurodegenerative disease,diagnostics,molecular diagnostics,clinical diagnostics ,laboratory medicine,biotechnology,early disease detection,assay development,infectious diseases,at home collection ,improved patient access,high-value diagnostic tests,and non-invasive sample collections

Veravas, inc operates in the Medical and diagnostic laboratories industry.

Veravas, inc's revenue is 11m - 100m

Veravas, inc has 11 - 50 employees.